Filter results
Category
Filter by document type
Document type
Filter by year
Sort by:

Search results

Showing 22 to 27 of 27 search results for IDD and BMR amendments.

  1. Brexit: information for retail investments firms in the UK

    Firms Published: 26/02/2019 Last modified: 21/06/2022
    If you have customers based in the EEA, find out what actions we expect you to have taken now the transition period is over.
  2. PS17/27: Insurance Distribution Directive implementation – Feedback to CP17/23 and near-final rules

    Policy statements Published: 24/07/2017 Last modified: 01/06/2018
    This is our second Policy Statement setting out near-final rules for the implementation of the Insurance Distribution Directive (IDD).
  3. CP21/15: Benchmarks Regulation: how we propose to use our powers over use of critical benchmarks

    Consultation papers Published: 20/05/2021 Last modified: 29/09/2021
    We are consulting on how we propose using two new powers introduced through amendments to the Benchmarks Regulation (BMR) under the Financial Services Act 2021 (FS Act).
  4. Derivation and changes tables

    Firms Published: 15/12/2023 Last modified: 15/12/2023
    This page contains an interactive version of the tables derivation and changes tables produced by the FCA in policy statements dealing with the repeal and replacement of retained EU law.
  5. LIBOR and the FCA's powers under the UK Benchmarks Regulation: questions and answers

    Firms Focus areas Markets Markets policy Published: 15/10/2021 Last modified: 09/01/2023
    In September 2021, we published information for firms to help manage an orderly wind-down of LIBOR. We explain this as well as information about our UK Benchmarks Regulation (BMR) powers.
  6. General insurance product value and coronavirus (Covid-19) Guidance – update

    Studies and reviews Multi-firm reviews Published: 25/08/2021 Last modified: 25/08/2021
    We set out the findings from our multi-firm review assessing how firms have responded to our general insurance (GI) distribution chain Guidance (further to the product governance rules implemented by the IDD) and coronavirus (Covid-19) value Guidance